← back to search

Ellen Ruud

Oslo University Hospital · NO
Area of research
Pediatrics, Perinatology and Child Health · Public Health, Environmental and Occupational Health
Research interest
Research interests include Childhood Cancer Survivors' Quality of Life, Acute Lymphoblastic Leukemia research, Cancer survivorship and care, and Family Support in Illness.
h-index
37
citations
4,590
works
167
NIH funding
primary concept
Medicine
email

Recent publications

The Development and Feasibility Testing of the Nurse-Led Transitioning Adolescents Off Cancer Treatment (TACT) Intervention.
2025cited by 1position: contributordoi
Neurocognitive outcome and associated factors in long-term, adult survivors of childhood acute lymphoblastic leukemia, treated without cranial radiation therapy.
2024cited by 7position: contributordoi
Life after paediatric brain tumour; the perspectives of the survivors and their parents.
2024cited by 4position: contributordoi
N-acetyl cysteine turns EPAC activators into potent killers of acute lymphoblastic leukemia cells.
2024cited by 0position: contributordoi
Exploring reported distress before and pain during needle insertion into a venous access port in children with cancer.
2023cited by 4position: contributordoi
Reduced exercise capacity is associated with left ventricular systolic dysfunction in long-term survivors of allogeneic hematopoietic stem-cell transplantation.
2023cited by 3position: contributordoi
The Physical Activity and Fitness in Childhood Cancer Survivors (PACCS) Study: Protocol for an International Mixed Methods Study.
2022cited by 15position: contributordoi
Impaired right ventricular function in long-term survivors of allogeneic haematopoietic stem-cell transplantation.
2021cited by 6position: contributordoi
The Physical Activity and Fitness in Childhood Cancer Survivors (PACCS) Study: Protocol for an International Mixed Methods Study (Preprint)
2021cited by 0position: contributordoi
Influence of Surgical Excision on the Survival of Patients With Stage 4 High-Risk Neuroblastoma: A Report From the HR-NBL1/SIOPEN Study
Journal of Clinical Oncology 2020cited by 122position: middledoi
Central nervous system relapse in high-risk stage 4 neuroblastoma: The HR-NBL1/SIOPEN trial experience
European Journal of Cancer 2020cited by 29position: middledoi
Risk stratification of high‐risk metastatic neuroblastoma: A report from the HR‐NBL‐1/SIOPEN study
Pediatric Blood & Cancer 2018cited by 75position: middledoi
PanCareLIFE: The scientific basis for a European project to improve long-term care regarding fertility, ototoxicity and health-related quality of life after cancer occurring among children and adolescents
European Journal of Cancer 2018cited by 53position: middledoi
Busulfan and melphalan versus carboplatin, etoposide, and melphalan as high-dose chemotherapy for high-risk neuroblastoma (HR-NBL1/SIOPEN): an international, randomised, multi-arm, open-label, phase 3 trial
The Lancet Oncology 2017cited by 344position: middledoi
Prospective study of thromboembolism in 1038 children with acute lymphoblastic leukemia: a Nordic Society of Pediatric Hematology and Oncology (NOPHO) study
Journal of Thrombosis and Haemostasis 2015cited by 60position: lastdoi
Cerebral sinus venous thromboses in children with acute lymphoblastic leukaemia – a multicentre study from the Nordic Society of Paediatric Haematology and Oncology
British Journal of Haematology 2014cited by 84position: middledoi
PEG‐asparaginase allergy in children with acute lymphoblastic leukemia in the NOPHO ALL2008 protocol
Pediatric Blood & Cancer 2014cited by 79position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 9 papers (2021–2025)Hanne C. Lie · University of Oslo5 papers (2021–2025)M.H. Larsen · Lovisenberg Diakonale Høgskole4 papers (2021–2024)Birgitte Klug Albertsen · Aarhus University3 papers (2014–2015) · 3 papers (2014–2015)Mats Heyman · Karolinska University Hospital3 papers (2014–2015)Sigmund A. Anderssen · Norwegian School of Sport Sciences2 papers (2021–2022) · 2 papers (2014–2015)Per Kogner · Karolinska University Hospital2 papers (2018–2020)Susi Kriemler · University of Zurich2 papers (2021–2022)Susanna Ranta · Karolinska University Hospital2 papers (2014–2015) · 2 papers (2014–2015)Shifra Ash · Technion – Israel Institute of Technology2 papers (2018–2020) · 2 papers (2014–2015)Ingrid Kristin Torsvik · Haukeland University Hospital2 papers (2021–2022)May Grydeland · Norwegian School of Sport Sciences2 papers (2021–2022)Kristin Ørstavik · Elsevier, Inc.2 papers (2021–2022)Henrik Brun · Oslo University Hospital2 papers (2021–2022)Martin Kaj Fridh · University of Copenhagen2 papers (2021–2022)Truls Raastad · Norwegian School of Sport Sciences2 papers (2021–2022)